US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist
  • 2.850
  • -0.060-2.06%
Close Jun 18 16:00 ET
  • 3.980
  • +1.130+39.65%
Post 19:59 ET
63.32MMarket Cap-1656P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tempest Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.36

+34.55%
Analyst Rating

Buy

Jun 19, 2024

Tempest Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Tempest Therapeutics Earnings Reports

  • Tempest Therapeutics | 10-Q: Quarterly report

    May 9 16:35 ET

  • Tempest Therapeutics | 10-K: Annual report

    Mar 19 16:41 ET

  • Tempest Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 17:25 ET

  • Tempest Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 19, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg